Litcius/Paper detail

Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori

Yuanyuan Dai, Chun Qin, Gan-Rong Huang, Yan-Chun Qin, Yong-Yi Huang, Yong-Yi Huang, Yan-Qiang Huang, Yan-Qiang Huang, Lijuan Zhao

2022Antimicrobial Agents and Chemotherapy11 citationsDOIOpen Access PDF

Abstract

Metronidazole (Met) is the first choice for treating Helicobacter pylori ( Hp ). However, Hp is easy to resistant, making Met unable to be widely used.

Topics & Concepts

MetronidazoleHelicobacter pyloriToxicityIn vivoPharmacologyGastric mucosaMicrobiologyDrug resistanceMedicineStomachAntibioticsChemistryGastroenterologyBiologyInternal medicineBiotechnologyHelicobacter pylori-related gastroenterology studiesClostridium difficile and Clostridium perfringens researchVeterinary medicine and infectious diseases
Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori | Litcius